Related Experiment Video
Updated: Nov 7, 2025

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Selective Inhibition of β-Catenin/Co-Activator Cyclic AMP Response Element-Binding Protein-Dependent Signaling
Haruna Matsuda-Hirose1, Tomoko Yamate1, Mizuki Goto1
1Department of Dermatology, Faculty of Medicine, Oita University, Oita, Japan.
Background:
The canonical Wnt/β-catenin signaling pathway is a fundamental regulatory system involved in various biological events. ICG-001 selectively blocks the interaction of β-catenin with its transcriptional co-activator cyclic AMP response element-binding protein (CBP). Recent studies have provided convincing evidence of the inhibitory effects of ICG-001 on Wnt-driven disease models, such as organ fibrosis, cancer, acute lymphoblastic leukemia, and asthma. However, the effects of ICG-001 in atopic dermatitis (AD) have not been investigated.
Objective:
To investigate whether β-catenin/CBP-dependent signaling was contributed in the pathogenesis of AD and ICG-001 could be a therapeutic agent for AD.
Methods:
We examined the effects of ICG-001 in an AD-like murine model generated by repeated topical application of the hapten, oxazolone (Ox). ICG-001 or vehicle alone was injected intraperitoneally every day during the development of AD-like dermatitis arising from once-daily Ox treatment.
Results:
Ox-induced AD-like dermatitis characterized by increases in transepidermal water loss, epidermal thickness, dermal thickness accompanied by increased myofibroblast and mast cell counts, and serum levels of thymic stromal lymphopoietin and thymus and activation-regulated chemokine, and decreases in stratum corneum hydration, were virtually normalized by the treatment with ICG-001. Elevated serum levels of periostin tended to be downregulated, without statistical significance.
Conclusion:
These results suggest that β-catenin/CBP-dependent signaling might be involved in the pathogenesis of AD and could be a therapeutic target.
Insights
ICG-001, a Wnt/β-catenin signaling inhibitor, effectively normalized skin barrier function and inflammation in an atopic dermatitis (AD) mouse model. This suggests targeting β-catenin/cyclic AMP response element-binding protein (CBP) signaling is a promising therapeutic strategy for AD.
Area of Science:
- Dermatology
- Molecular Biology
- Immunology
Background:
- The Wnt/β-catenin signaling pathway regulates critical biological processes.
- ICG-001 inhibits the β-catenin/cyclic AMP response element-binding protein (CBP) interaction.
- ICG-001 has shown efficacy in various Wnt-driven disease models, but its role in atopic dermatitis (AD) is unexplored.
Purpose of the Study:
- To determine if β-catenin/CBP signaling contributes to AD pathogenesis.
- To evaluate ICG-001 as a potential therapeutic agent for AD.
Main Methods:
- An AD-like murine model was established using topical oxazolone (Ox) application.
- Mice received daily intraperitoneal injections of ICG-001 or vehicle during dermatitis development.
Main Results:
- ICG-001 treatment normalized key AD markers, including transepidermal water loss, epidermal and dermal thickness, and stratum corneum hydration.
- Oxazolone-induced increases in myofibroblast and mast cell counts, and serum levels of thymic stromal lymphopoietin and thymus and activation-regulated chemokine were reversed by ICG-001.
- Elevated serum periostin levels showed a non-significant trend toward downregulation with ICG-001 treatment.
Conclusions:
- β-catenin/CBP-dependent signaling appears to play a role in AD pathogenesis.
- ICG-001 demonstrates therapeutic potential for treating atopic dermatitis.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
GPCR Desensitization
Hedgehog Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
MAPK Signaling Cascades

